Evofem Biosciences, Inc. (EVFM)
OTCMKTS
· Delayed Price · Currency is USD
0.0096
+0.0006 (6.67%)
Dec 26, 2024, 12:16 PM EST
Evofem Biosciences Revenue
Evofem Biosciences had revenue of $4.50M in the quarter ending September 30, 2024, a decrease of -12.05%. This brings the company's revenue in the last twelve months to $17.10M, up 26.09% year-over-year. In the year 2023, Evofem Biosciences had annual revenue of $18.22M with 8.20% growth.
Revenue (ttm)
17.10M
Revenue Growth
+26.09%
P/S Ratio
0.03
Revenue / Employee
449.95K
Employees
38
Market Cap
1.03M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.66B |
Ryman Healthcare Limited | 458.44M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |
Evofem Biosciences News
- 5 weeks ago - Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 - PRNewsWire
- 7 weeks ago - Evofem Secures Investor Support for Proposed Merger through Voting Agreements - PRNewsWire
- 4 months ago - Evofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution - PRNewsWire
- 4 months ago - Evofem Biosciences GAAP EPS of $0.00, revenue of $4.16M - Seeking Alpha
- 4 months ago - Evofem Biosciences Announces Financial Results for the Second Quarter of 2024 - PRNewsWire
- 5 months ago - Evofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1st - GlobeNewsWire
- 5 months ago - Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1 - PRNewsWire
- 5 months ago - Lupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSEC - PRNewsWire